We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+10.91%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$470B
AUM Growth
+$74.8B
Cap. Flow
+$24.4B
Cap. Flow %
5.19%
Top 10 Hldgs %
30.35%
Holding
14,310
New
2,075
Increased
5,756
Reduced
4,471
Closed
1,856

Sector Composition

Rank Sector Weight
1 Technology 2.31%
2 Consumer Discretionary 1.61%
3 Financials 1.35%
4 Healthcare 1.15%
5 Communication Services 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRNT
12151
PUT
DELISTED
IronNet, Inc.
IRNT
$9.94K ﹤0.01%
+28,400
New +$11.2K
SURF
12152
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$9.93K ﹤0.01%
14,215
-35,600
-71% -$28.8K
FTK icon
12153
PUT
Flotek Industries
FTK
$869M
$9.87K ﹤0.01%
2,383
-2,284
-49% -$15K
SNMP
12154
DELISTED
Evolve Transition Infrastructure LP
SNMP
$9.85K ﹤0.01%
+1,635
New +$10.4K
DNA.WS
12155
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$9.78K ﹤0.01%
54,355
TFFP
12156
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$9.77K ﹤0.01%
570
-396
-41% -$8.58K
IMPP icon
12157
PUT
Imperial Petroleum
IMPP
$231M
$9.6K ﹤0.01%
3,367
-9,586
-74% -$33K
CRVS icon
12158
Corvus Pharmaceuticals
CRVS
$1.22B
$9.5K ﹤0.01%
+10,443
New +$8.15K
CPTN
12159
DELISTED
Cepton, Inc. Common Stock
CPTN
$9.44K ﹤0.01%
+2,033
New +$20.1K
UP icon
12160
PUT
Wheels Up
UP
$181M
$9.32K ﹤0.01%
74
-31
-30% -$6.88K
PAVM icon
12161
PAVmed
PAVM
$42.2M
$9.19K ﹤0.01%
55
+19
+53% +$4K
BNIXR
12162
DELISTED
Bannix Acquisition Corp. Right
BNIXR
$9.06K ﹤0.01%
64,796
-13,933
-18% -$2.08K
TTNP
12163
CALL
DELISTED
Titan Pharmaceuticals
TTNP
$9.05K ﹤0.01%
545
-580
-52% -$10.4K
ELYS
12164
CALL
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$9.03K ﹤0.01%
+17,700
New +$11.3K
GOVX icon
12165
GeoVax Labs
GOVX
$3.34M
$8.9K ﹤0.01%
36
-73
-67% -$20.5K
DOGZ icon
12166
Dogness International Corp
DOGZ
$17.8M
$8.82K ﹤0.01%
+595
New +$11.2K
ABVC icon
12167
ABVC BioPharma
ABVC
$21.3M
$8.77K ﹤0.01%
1,392
+389
+39% +$2.78K
XELA
12168
PUT
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$8.62K ﹤0.01%
1,077
+1,022
+1,858% +$12.4K
PPHPR
12169
DELISTED
PHP Ventures Acquisition Corp. Rights
PPHPR
$8.57K ﹤0.01%
52,443
-8,100
-13% -$1.6K
CELG.RT
12170
Bristol-Myers Squibb Rights
CELG.RT
$244M
$8.48K ﹤0.01%
67,336
+17,150
+34% +$2.28K
SNAX
12171
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$8.27K ﹤0.01%
1,137
-626
-36% -$6.38K
GROV icon
12172
Grove Collaborative
GROV
$41.8M
$8.27K ﹤0.01%
3,776
-857
-18% -$1.98K
ZEV
12173
PUT
DELISTED
Lightning eMotors, Inc.
ZEV
$8.18K ﹤0.01%
1,410
+495
+54% +$5.77K
PAVMZ
12174
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
$8.14K ﹤0.01%
+67,868
New +$13.4K
DTEA
12175
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$8.03K ﹤0.01%
16,701
-40,018
-71% -$35.1K

Similar funds

Jeff Yass's Q1 2023 Portfolio in Review

As of Q1 2023, Jeff Yass held 14,310 positions worth $470B, up 19% from $395B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass deployed $24.4B of net new capital in Q1 2023, opening 2,075 new positions and adding to 5,756 existing holdings. Its largest new stake was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M.

By sector, the portfolio is most concentrated in Technology at 2.3% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Tesla, an estimated $1.62B trimmed.

  • Jeff Yass's largest Q1 2023 buy was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.22B increase.
  • Jeff Yass's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.62B.
  • Jeff Yass fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $61.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $470B portfolio in Q1 2023.
  • Jeff Yass opened 2,075 new positions and closed 1,856 in Q1 2023.
  • Jeff Yass's portfolio value rose 19% quarter-over-quarter to $470B.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.